Schellhorn out, Emerson in as Monteris CEO
Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year.
Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year by BTG (LON:BTG). Prior to his time with Galil, Emerson acted as prez and CEO of American Medical Systems Holdings, and has held positions at Boston Scientific (NYSE:BSX) and Baxter (NYSE:BAX).
“We are pleased and privileged to have an executive with Marty Emerson’s experience and track record take over the reins at Monteris Medical. He has both the leadership and market knowledge necessary to build Monteris into a world-class medical device company,” Monteris Medical board chair Greg Barrett said in a press release.
“I would like to thank the Monteris board of directors for the opportunity to lead a company with such exciting technology offering minimally invasive surgical alternatives to patients with brain tumors and epilepsy. I look forward to working with the talented Monteris management team to meet the high expectations of the company’s investors, physicians and their patients,” Emerson said in prepared remarks.
